Trudhesa is a Nasal Spray, Metered in the Human Prescription Drug category. It is labeled and distributed by Impel Pharmaceuticals Inc.. The primary component is Dihydroergotamine Mesylate.
| Product ID | 77530-725_07e234fc-6c12-4c57-a6ac-1988b0edbfd2 |
| NDC | 77530-725 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Trudhesa |
| Generic Name | Dihydroergotamine Mesylate |
| Dosage Form | Spray, Metered |
| Route of Administration | NASAL |
| Marketing Start Date | 2021-09-24 |
| Marketing Category | NDA / |
| Application Number | NDA213436 |
| Labeler Name | Impel Pharmaceuticals Inc. |
| Substance Name | DIHYDROERGOTAMINE MESYLATE |
| Active Ingredient Strength | 4 mg/mL |
| Pharm Classes | Ergotamine Derivative [EPC], Ergotamines [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2023-12-31 |
| Marketing Start Date | 2021-09-24 |
| NDC Exclude Flag | N |
| Sample Package? | Y |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 77530-725 | Trudhesa | Dihydroergotamine mesylate |
| 66490-041 | D.H.E. 45 | Dihydroergotamine Mesylate |
| 0143-9273 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 0574-0850 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 0574-0851 | dihydroergotamine mesylate | dihydroergotamine mesylate |
| 24201-463 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 25021-609 | dihydroergotamine mesylate | dihydroergotamine mesylate |
| 61990-0411 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 68682-357 | Dihydroergotamine Mesylate | dihydroergotamine mesylate |
| 81284-411 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 82454-0411 | Dihydroergotamine Mesylate | Dihydroergotamine Mesylate |
| 70529-030 | Dromelate | Dihydroergotamine Mesylate |
| 0187-0245 | Migranal | dihydroergotamine mesylate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() TRUDHESA 90885069 not registered Live/Pending |
Impel NeuroPharma, Inc. 2021-08-16 |
![]() TRUDHESA 88578186 not registered Live/Pending |
Impel NeuroPharma, Inc. 2019-08-14 |